Status:
NOT_YET_RECRUITING
Testicular Adrenal Rest Tumor in Congenital Adrenal Hyperplasia Patients Attending Assuit University Children Hospital
Lead Sponsor:
Assiut University
Conditions:
Testicular Adrenal Rest Tumor
Congenital Adrenal Hyperplasia
Eligibility:
MALE
4-18 years
Brief Summary
assessment of the risk factors contributing for TART development in a male child with congenital adrenal hyperplasia.
Detailed Description
Congenital adrenal hyperplasia (CAH) is one of the most frequent endocrine disorders. It is characterized by deficient activity of one of the enzymes necessary for adrenal Cortisol synthesis. Autosoma...
Eligibility Criteria
Inclusion
- All male patients diagnosed as congenital adrenal hyperplasia based on clinical manifestations and laboratory investigations from age of 4 years to age of 18 years.
Exclusion
- Patients with other adrenal insufficiency cause and Congenital adrenal hyperplasia that progressed to true precocious puberty
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06564220
Start Date
October 1 2024
End Date
December 1 2025
Last Update
August 21 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.